Intra-Cellular Therapies Inc. buy Mizuho
Start price
22.04.24
/
50%
€70.50
Target price
22.04.25
€90.20
Performance (%)
-4.96%
Price
23.08.24
€67.00
Summary
This prediction is currently active. With a performance of -4.96%, the BUY prediction for Intra-Cellular Therapies Inc. by Mizuho is down slightly. This prediction currently runs until 22.04.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -2.899% | -2.899% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $82.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
21.06.24
21.06.24
€93.48
21.06.25
21.06.25
-5.63%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.30
17.02.24
17.02.24
€76.07
17.02.25
17.02.25
-3.32%
23.08.24
23.08.24